Repositioning Safety

May 22, 2020Blog

There is an urgent need for the healthcare industry to reposition safety: that is to change how the ability to discover, possess information about and act on predicted Adverse Drug Reactions (ADR) is perceived and treated by pharma companies, the regulator and other stakeholders.  To date drug testing has been biased toward minimizing “Type I” … Read More